On July 12th, JPMorgan raised Eli Lilly and Co's target price from $900 to $1,000 and maintained a "shareholding" rating.
摩根大通上调礼来目标价至1000美元
JPMorgan raised Eli Lilly and Co's target price to $1,000.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.